DiaSorin S.p.A. DIA
MIL · Italy · Health Technology
€74.00-2.80 (-3.65%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
PLYMOUTH MEETING, Pa., September 08, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chief Financial Officer, effective September 9, 2026. Mr. Currie will assume CFO responsibilities from Jason Clemens, who will assist with the transition throu
Diasorin SpA (DSRLF) reports a 4% revenue increase in Q2 2026, driven by a U.S. immunodiagnostics recovery and strong Liaison Plex traction, while navigating China declines and tariff headwinds.
Wondering if DiaSorin at €61.66 still reflects its true worth, or if the market is missing something you can spot before others do? The share price has seen a 5.8% gain over the last 7 days, alongside declines of 10.3% over the last 30 days, 9.9% year to date, and 33.0% over the past year, so recent moves may be changing how investors think about both risk and opportunity here. Recent coverage around DiaSorin has focused on its position in the Medical Equipment space and how sentiment has...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.